They had a someone, but there is a huge disagreement about this person. He is too close to big pharma. They want someone who isn't, but $$$ and lobbyist make it too tempting for anyone. They need to change the whole system while they are at it.
I don't know if anyone posted this conference yet. It looks interesting.